Zecotek Medical Systems Inc.
TSX VENTURE : ZMS

Zecotek Medical Systems Inc.

July 06, 2005 09:30 ET

Zecotek Medical Systems Inc.: Letter of Intent Extended

VANCOUVER, BRITISH COLUMBIA--(CCNMatthews - July 6, 2005) - Zecotek Medical Systems Inc. (the "COMPANY" or "ZMS") (TSX VENTURE:ZMS) -

Further to the Company's news release of April 13, 2005, Dr. Faouzi Zerrouk reports that the Letter Of Intent between Synoptics, an affiliate of Northrop Grumman Corporation Space Technology ("Synoptics") and Zecotek Medical Systems Inc. has been extended until July 31, 2005. The original Letter of Intent had an expiry date of June 30, 2005 unless extended.

Dr. Zerrouk confirms that the technology transfer to Synoptics relating to the growth of the LFS Scintillation material has been completed and that Synoptics has experienced much success in the growth of the LFS at its facility.

Negotiations continue toward a final agreement relating to the establishment of a Joint Development Relationship and the execution of a license for the manufacture of Zecotek's LFS scintillation material by Synoptics.

Zecotek Medical Systems Inc. is a market driven, Research and Development bio-photonics company with laboratories and base at the University of British Columbia. ZMS focuses on the creation of advanced materials and integrated optoelectronic devices for high resolution medical imaging, optical precision surgery and biopharmaceutical research. ZMS grows by developing and acquiring Intellectual Property and technology know-how through a very thorough selection mechanism which involves industry leaders and constant interaction with major end-users. ZMS commercializes its technologies through strategic alliances with leading OEM manufacturers and distributors.

On Behalf of the Board,

Dr. A.F.Zerrouk, Chairman & CEO

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.

Contact Information

  • Zecotek Medical Systems Inc.
    Grant Macdonald
    (604) 689-4200